Toggle navigation
Home
Search
Services
Blog
Contact
About
Phase 2 Clinical Trial of an Anti-Androgen and A 5-Alpha Reductase Inh-261075017
Mayo Foundation
Search grants from Mayo Foundation
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Comments
Recent in Grantomics:
Ohio State University
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
The 2019 Conference of the United States Human Proteome Organization (US HUPO)
Animal Models
VA Low Vision Intervention Trial (LOVIT) II
Induction of Phase 2 Genes by Chemopreventive Agent BHA
Impulse Conduction Block in Injured Central Axons
Recently added grants:
Linkage of s100a10 (p11) to enteric 5-HT4-mediated serotonergic signaling roles in GI motility, enteric nervous system development, and co-morbid dysfunction of gut and brain
Program to enrich translation and multimodal research in Alzheimers disease and related dementias
IMSD at Rush University
Advanced Technologies - National Center for Image Guided Therapy (AT-NCIGT)
Administration Core
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research and Development Contracts (N01)
Project #
N01CA075017-008
Application #
7329467
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
2006
Total Cost
Indirect Cost
Institution
Name
Mayo Foundation
Department
Type
DUNS #
City
State
Country
Zip Code
Related projects
NIH 2006
N01 CA
Phase 2 Clinical Trial of an Anti-Androgen and A 5-Alpha Reductase Inh-261075017
/ Mayo Foundation
NIH 2003
N01 CA
Phase 2 Clinical Trial of an Anti-Androgen and A 5-Alpha Reductase Inh-261975017
/ Mayo Foundation
Comments
Be the first to comment on this grant